Related Experiment Videos
Parkinsonian side effects induced by a monoamine oxidase inhibitor
The American Journal of Psychiatry
|January 1, 1984
Abstract:
A 75-year-old depressed woman treated with the monoamine oxidase inhibitor (MAOI) phenelzine developed a parkinsonian syndrome that remitted after discontinuation of the drug. The authors discuss possible explanations for this unusual phenomenon.